Hilton San Francisco Financial District, San Francisco, US
Innovation, collaboration and best practice for pharma, biotech and partners
Conference day two: Wednesday 1st February
Please enable javascript to see more information on speakers
Collaboration | |||
| 8am | Registration and coffee | ||
| 8.50am | Chairman’s opening remarks | ||
The public-private partnership | |||
| 9am |
Building a public-private partnership to address urgent medical needs
| ||
| 9.20am |
Nurturing academic incubators to bring innovative science to market
| ||
| 9.40am |
A novel public-private partnership
| ||
| 10am |
Applying chemical knowledge to build improvement across industry
| ||
| 10.20am |
Discovering answers to unmet medical needs through collaborative alliances
| ||
| 10.40am | Morning coffee break | ||
External resourcing | |||
| 11.10am |
Building strategic partnerships to maintain lean internal business
| ||
| 11.30am |
Planning for the longevity of external alliances
| ||
| 11.50am |
Catalyzing collaboration through early stage research partnerships
| ||
| 12.10pm |
Bringing together stakeholders with a shared goal
| ||
| 12.30pm | Networking lunch | ||
| 1.30pm |
Panel session: finding the right partner when looking for innovation Dr. Jeff WarmkeDr. Warmke is currently Senior Vice President, Daiichi Sankyo Group and leads the External Scientific Affairs group responsible for identification and evaluation of Product Licensing and Research and Development collaboration opportunities, and he... more.. Dr. Christopher HaskellChristopher Haskell leads Bayer’s U.S. Science Hub, based in the company’s U.S. Innovation Center located at Mission Bay, San Francisco. Charged with expanding Bayer’s collaborations with academic research institutions and life science firms, the... more.. Dr. Louis DeGennaroAs Chief Mission Officer, Dr. DeGennaro's current responsibilities include oversight of all LLS mission functions: Public Policy, Patient Services and Research with the goal of effectively deploying resources in pursuit of the LLS mission to cure... more..
| ||
Virtual platforms | |||
| 2.10pm |
Research Exchanges: bringing the best of the web to science
| ||
| 2.30pm |
Tapping the long tail of knowledge in the crowd
| ||
| 2.50pm |
The biopharma facebook: social networking for science
| ||
| 3.10pm |
Accelerating clinical development: establishing a clinical research commons
| ||
| 3.30pm | Afternoon coffee break | ||
Pre-competitive collaboration | |||
| 4pm |
Running a pre-competitive research group to advance knowledge
| ||
| 4.20pm |
Troubleshooting to a solution: encouraging smart scientific conversations
| ||
| 4.40pm |
Panel: drawing the line for what constitutes pre-competitive knowledge Dr. Tim WillsonTimothy M. Willson is Director of Chemical Biology at GlaxoSmithKline (GSK) in Research Triangle Park NC, where he leads a multidisciplinary team in the identification of innovative targets for drug discovery. Current areas of focus include chemical ... more.. Dr. Tariq GhayurTariq Ghayur received a Ph.D in Immunology from McGill University, Montreal, Canada. He did his post-doctoral training at McGill (1986-’88) and Dana Farber Cancer Institute (1988-’90). He joined BASF Pharma (1990), which was acquired by Abbott... more.. Dr. Alpheus BinghamDr. Bingham is a member of the Board and co-founder of InnoCentive, Inc. He has been a strong advocate of open innovation and founded InnoCentive, Inc., along with other ventures that create the advantages of open and networked organizational... more.. Dr. Barry BuninBarry A. Bunin, Ph.D. is the CEO of Collaborative Drug Discovery. Dr. Bunin has overseen over $20 million in business transactions. Prior to CDD, Dr. Bunin was an Entrepreneur in Residence with Eli Lilly & Co. Before that he was the founding... more..
| ||
| 5.20pm | Close of day two followed by networking drinks reception |
Register for World Pharma Innovation Congress USA ›
